Where is AIT located?

AIT is headquartered in Sunnyvale, United States. It is registered at 851 STELLA COURT SUNNYVALE CA 94087.

How many employees does AIT have?

As of Jul 31, 2026, the latest employee count at AIT is 5.

Is AIT a funded company?

AIT is a funded company, having raised a total of $1.11M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round.

When was the latest funding round of AIT?

AIT's latest funding was a $***** Series A round on Mar 23, 2012, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does AIT rank among its competitors?

AIT ranks 142nd amongst 379 active competitors, of which 41 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Abselion, which secured $8.41M in Oct, 2024.

Who are the top competitors of AIT?

AIT's top competitors include Siemens Healthineers, Illumina and Quanterix. Among them, Abselion secured the most recent funding round in October, 2024.

AIT - 2026 Company Profile, Funding & Competitors

AIT is a series A company based in Sunnyvale (United States), founded in 2003. It operates as a Provider of building, construction, and landscaping services. AIT has raised $1.11M in funding. The company has 379 active competitors, including 41 funded and 54 that have exited. Its top competitors include companies like Siemens Healthineers, Illumina and Quanterix.

Company Details

Provider of building, construction, and landscaping services. They undertake home extensions and alterations, new builds, driveways and landscaping projects, and commercial works. Services include residential housing developments, from concept to completion, and a range of groundworks. They also offer commercial construction and maintenance services. The company holds CHAS safety and ISO 9001 quality management accreditations.

Website: sidms.com
Email ID: *****@sidms.com
Phone Number: +1 **********
Part Of
Registered Address: 851 STELLA COURT SUNNYVALE CA 94087

Key Metrics

Founded Year

2003

Location

Sunnyvale, United States

Stage

Series A

Total Funding

$1.11M in 2 rounds

Latest Funding Round

Series A, Mar 23, 2012, $*****

Investors

Revelis Capital Group

Ranked

142^nd among 379 active competitors

Employee Count

5 as on Jul 31, 2026

Similar Companies

Siemens Healthineers & 426 more

View AIT's full profile

AIT is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
APPLIED ISOTOPE TECHNOLOGIES CIN: C2434214 , United States, Active	May 13, 2003	-	-	-

AIT has raised a total funding of $1.11M over 2 rounds. AIT has 1 institutional investor.

Here is the list of recent funding rounds of AIT:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 23, 2012	9534257	Series A	7151751	9082909	8695150	3583781

Access funding benchmarks and valuations. Sign up today!

View details of AIT's funding rounds and investors

AIT's employee count trend

AIT has 5 employees as of Jul 26. Here is AIT's employee count trend over the years:

Uncover AIT's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of AIT include Siemens Healthineers, Illumina and Quanterix. Here is the list of Top 10 competitors of AIT, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Siemens Healthineers 2017, Forchheim (Germany), Public	Provider of medical imaging laboratory diagnostics and clinical digital solutions	-	Qatar Investment Authority, Skyviews Life Science ... & 3 others	75/100
2nd	Illumina 1993, San Diego (United States), Public	Developer of technologies for analysis of genetic variation and function	$28M	Chevron Technology Ventures, Dow Chemical Company ... & 32 others	71/100
3rd	Quanterix 2007, Cambridge (United States), Public	Developer of assay kits for ultra-sensitive biomarker detection	$99.5M	T. Rowe Price, Novalis LifeSciences & 15 others	71/100
4th	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
5th	Biocare Medical 1997, Concord (United States), Acquired	Manufacturer of primary antibodies and instruments for immunohistochemistry applications	$85M	Excellere Partners, GHO Capital Partners & 3 others	65/100
6th	MGI 2016, Shenzhen (China), Series B	Provider of gene sequencing instruments, reagents, equipment, and related products	$1B	Guotai Junan Securities, CoStone Capital ... & 13 others	63/100
7th	Bio-Techne 1981, Minneapolis (United States), Acquired	Developer of biotech reagents, instruments and clinical diagnostic products	-	HHS	59/100
8th	Abselion 2018, Cambridge (United Kingdom), Series A	Provider of a benchtop instrument for protien research	$12.6M	University of Cambridge, M Ventures & 13 others	59/100
9th	Applied BioCode 2008, Santa Fe Springs (United States), Public	Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications	$20.3M	ID Ventures America, TPTF & 4 others	59/100
10th	Bio Rad 1952, Hercules (United States), Public	Portfolio of products and services for life science research and clinical diagnostic markets	-	Bellevue Healthcare Trust, SMB Capital Partners ... & 3 others	58/100
142nd	AIT 2003, Sunnyvale (United States), Series A	Provider of building, construction, and landscaping services	$1.11M	Revelis Capital Group	28/100